Navigation Links
Bacteria are key to 'green' plastics, drugs

se farm-grown products like grain sorghum as feedstocks for the succinate-producing bacteria.

"We are very pleased for the opportunity to continue our collaboration with our colleagues from Rice and work to further the development and commercialization of the succinate technology," said Praveen Vadlani, principal research scientist for AgRenew. "We are excited about the prospects this project offers to meet a market need for the benefit of both institutions and American agriculture itself. We also appreciate the support of the U.S. Department of Agriculture for this work to create another high-value product from agriculture."

Many researchers are trying to create a succinate-producing bacterial mutant. They use biotechnology to either insert genes that boost succinate production or delete genes that interfere with it. The goal is to maximize the rate -- the speed of the conversion -- and the yield -- the amount of succinate produced per pound of glucose converted.

Bennett and San's bug -- known only by the designation SBS550MG -- contains an ingenious bit of metabolic engineering that allows it to produce succinate in two different ways. One method exists in wild strains of E. coli and has been modified with the deletion of four genes, each of which codes for a protein that interferes with or limits E. coli's ability to turn glucose into succinate. Bennett and San activated a second pathway and stimulated production by adding genes from lactococcus bacteria and sorghum.

Each genetic pathway metabolizes glucose and produces succinate via dissimilar chemical reactions. That means the two don't compete or interfere with one another. In fact, Bennett and San designed the paths to be complimentary, but even so, they were gratified to see how well the process worked once both paths were put in place.

"Our experiments in the laboratory have produced near-maximum yields, with almost all the glucose being converted into succinate," sai
'"/>

Source:Rice University


Page: 1 2 3

Related biology news :

1. Bacteria collection sheds light on urinary tract infections
2. Solution to Pollution: New Bacteria Eats Toxic Waste
3. The Bacterias guide to survival
4. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
5. Bacterial genome sheds light on synthesizing cancer-fighting compounds
6. Where Bacteria Get Their Genes
7. Bacteria feed on smelly breath (and feet)
8. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
9. Bacteria use hosts immune response to their competitive advantage
10. Say what? Bacterial conversation stoppers
11. Researchers Discover Ancient Origins Of Tuberculosis-causing Bacteria

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bacteria are key green plastics drugs

(Date:12/3/2009)...els that repels grime and dirt? Expanded battery s...el Aviv University research, just published in Na...sembling peptides at the nano-scale level that cou... a few years. , Operating in the range of 100 na...en smaller, graduate student Lihi Adler-Abramovich...
(Date:12/3/2009)...nality change in warmer water, according to an int...ay make some species more aggressive. , Experime...lia,s Great Barrier Reef have shown for the first ...imid, or consistently bold, and that these individ...eratures rise. , A slight lift of just one or tw...
(Date:12/3/2009)...m the U.S. Department of Energy,s (DOE) Brookhaven...Indian Institute of Science has made a major step ...information in DNA that is necessary to carry out ...ished in the December 1, 2009 edition of Nature S... proteins responsible for interacting at specific ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 1Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 2maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 1maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 2maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 3Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 1Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 2Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 3Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 4
...f the 2006-2007 activities of UC San Diegos engine...y they recently took home the nations most outstan...oss fundraiser. , Youll find the detailed lesson ...ineering and science fundamentals to 75 fifth grad... find all kinds of information about the tutoring ...
...ajor role in an international scientific team that...ely related fruit fly species. As well has having ...tation to evolving immune systems -- the analysis ...on of each species., From the results of the resea... two papers published this week in the journal Nat...
...y of Idaho researchers are crossing academic and g...ses against Staphylococcus aureus bacteria and oth... effort is to create much faster and more accurate...otic methicillin, formally known as methicillin-re...rough detection technologies are already in hand i...
Other Biology News:UC-San Diego Engineering Honor Society wins most outstanding chapter award 2International team compares 12 fruit fly genomes 2International team compares 12 fruit fly genomes 3Developing kryptonite for Superbug 2Developing kryptonite for Superbug 3Developing kryptonite for Superbug 4Developing kryptonite for Superbug 5
(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Drug Discovery Technologies - A G... ,, http://www.reportlinker.com/p0164246/Drug-...-Trends--Opportunities.html ,, Drug discovery ...y pharmaceutical company,s business strategy. Ther...
(Date:12/2/2009)...c. 2 Peregrine Pharmaceu...etion of patient enrollment in a dose confirmation...ith relapsed glioblastoma multiforme (GBM), the de...d monoclonal antibody linked to a radioisotope bei... Cotara specifically targets cells at the center ...
(Date:12/2/2009)...therlands, December 2 Pepscan Hold...y focusing on protein mimicking,technology for the... that it,has appointed Wim E.M. Mol, Ph.D. as new ...e responsible for all of Pepscans corporate functi...tion of the company. He brings to,Pepscan more tha...
(Date:12/2/2009)... 2 S*BIO Pte Ltd today announced d..., SB1518, at The American Society of Hematology 51..., Data will be presented on the clinical result... detailing its safety, tolerability and pharmacoki...ls ranging from 100 to 600 mg. These doses were ad...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...evelopment, Biomarker Identification ..., Oct. 10 MultiCell,Technologies, Inc. (OTC Bulle...ve license and technology purchase agreement with ... Company,s Fa2N-4 immortalized,adult human liver c...and has agreed to purchase,certain inventory and e...
...herapeutics Corporation (Nasdaq: TARG ) today ann...of 5,750,000 shares of its common stock at a price...res are being offered by,Targanta. Targanta has gr...ase up to an additional 862,500 shares of common s...ing discounts and commissions, to cover,over-allot...
...efits of Unsaturated Fatty Acids in ... 10 Amarin Corporation plc,(NASDAQ: AMRN ) today...development strategy to capitalize on the known th...ardiovascular disease. Amarin plans to utilize,its...e to develop a series,of products targeting the va...
Other Biology Technology:MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated 2MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated 3Targanta Therapeutics Announces Pricing of its Initial Public Offering 2Amarin Announces Initiation of Cardiovascular Development Strategy 2Amarin Announces Initiation of Cardiovascular Development Strategy 3Amarin Announces Initiation of Cardiovascular Development Strategy 4Amarin Announces Initiation of Cardiovascular Development Strategy 5
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
UltraClean Microbial DNA Isolation Kit from Mo Bio Laboratories, Inc.
Custom Oligo Assay Single Locus 1920 samples from Illumina
Anti-Human L-Ficolin Monoclonal Antibody, Unconjugated, Clone GN4 from Cell Sciences
Biology Products: